ASEP Medical
Asep Inc. is dedicated to advancing patient care by developing innovative diagnostic and therapeutic solutions to combat antibiotic-resistant infections and sepsis. The company consolidates three development-stage companies—Sepset Bioscience, ABT Innovations, and SafeCoat Medical—and aims to mitigate the global crisis of antibiotic failure through rapid diagnostics and effective treatments. With extensive intellectual property, a large addressable global market, and a team of experienced leaders, Asep Inc. strives to become a global leader in the diagnosis and treatment of antibiotic-resistant infections.
Industries
Nr. of Employees
small (1-50)
ASEP Medical
Victoria, British Columbia, Canada, North America
Products
Rapid gene-signature sepsis diagnostic assay
A blood-based diagnostic assay using gene-expression signatures and AI to provide rapid (~1 hour) risk assessment and stratification for sepsis and related severe infections.
Peptide-based antibiofilm therapeutic and device coatings
Patented cationic peptide therapeutics with broad-spectrum activity against biofilm-associated, antibiotic-resistant bacteria, and substrate-independent peptide coatings designed to reduce device-related infections and improve sterile surfaces.
Rapid gene-signature sepsis diagnostic assay
A blood-based diagnostic assay using gene-expression signatures and AI to provide rapid (~1 hour) risk assessment and stratification for sepsis and related severe infections.
Peptide-based antibiofilm therapeutic and device coatings
Patented cationic peptide therapeutics with broad-spectrum activity against biofilm-associated, antibiotic-resistant bacteria, and substrate-independent peptide coatings designed to reduce device-related infections and improve sterile surfaces.
Services
Partnerships, licensing and joint-venture development
Structuring and executing licensing agreements and joint ventures to support regional regulatory approval and commercialization of diagnostic and therapeutic technologies.
Clinical and preclinical study coordination
Design, conduct and coordination of preclinical efficacy studies and clinical validation studies for diagnostics and therapeutics, including independent study collaborations.
Partnerships, licensing and joint-venture development
Structuring and executing licensing agreements and joint ventures to support regional regulatory approval and commercialization of diagnostic and therapeutic technologies.
Clinical and preclinical study coordination
Design, conduct and coordination of preclinical efficacy studies and clinical validation studies for diagnostics and therapeutics, including independent study collaborations.
Expertise Areas
- Sepsis diagnostics and stratification
- Antibiofilm and peptide therapeutics
- Peptide-based medical device coatings
- Diagnostic AI and machine-learning models
Key Technologies
- Gene-expression profiling
- AI / machine learning for diagnostics
- Biomarker signature assays
- Peptide therapeutics